Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1663869 | 0.99 | MAPT (0.58) | MAPTKMT2ARAB9AMEN1POLB | |
| SCHEMBL8769706 | 0.81 | RAB9A (0.58) | MAPTKMT2ARAB9AMEN1TP53 | |
| SCHEMBL1664038 | 0.80 | MAPT (0.49) | MAPTKMT2ARAB9AMEN1TP53 | |
| SCHEMBL21254707 | 0.80 | MAPT (0.73) | MAPTKMT2ARAB9AMEN1POLB | |
| SCHEMBL1665855 | 0.80 | MAOA (0.53) | MAPTKMT2ARAB9AMEN1POLB | |
| SCHEMBL1665250 | 0.79 | RAB9A (0.53) | MAPTKMT2ARAB9AMEN1TP53 | |
| SCHEMBL1665248 | 0.79 | NPC1 (0.51) | MAPTKMT2ARAB9AMEN1TP53 | |
| SCHEMBL1664252 | 0.79 | MAPT (0.50) | MAPTKMT2ARAB9AMEN1TP53 | |
| SCHEMBL1665857 | 0.79 | MAOA (0.52) | MAPTKMT2ARAB9AMEN1POLB | |
| SCHEMBL1664756 | 0.79 | RAB9A (0.52) | MAPTKMT2ARAB9AMEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2642994-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | Ligand Pharmaceuticals Incorporated (US) | 2013-10-02 | — | — | EP | disclosed |
| EP-2488486-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | Ligand Pharmaceuticals Inc. (US) | 2012-08-22 | — | — | EP | disclosed |
| WO-2012068406-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2011046954-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | LIGAND PHARMACEUTICALS INC. (US) | 2011-04-21 | — | — | WO | disclosed |